{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Depression & mood disorders",
      "PSYCHIATRY"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28689181",
  "DateCompleted": {
    "Year": "2018",
    "Month": "01",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "07",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1136/eb-2017-102627"
    ],
    "Journal": {
      "ISSN": "1468-960X",
      "JournalIssue": {
        "Volume": "20",
        "Issue": "3",
        "PubDate": {
          "Year": "2017",
          "Month": "Aug"
        }
      },
      "Title": "Evidence-based mental health",
      "ISOAbbreviation": "Evid Based Ment Health"
    },
    "ArticleTitle": "Subthreshold hypomania affects half of patients with bipolar disorder presenting with depressive symptoms.",
    "Pagination": {
      "StartPage": "e14",
      "MedlinePgn": "e14"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "McIntyre",
        "ForeName": "Roger S",
        "Initials": "RS"
      }
    ],
    "PublicationTypeList": [
      "Editorial",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Evid Based Ment Health",
    "NlmUniqueID": "100883413",
    "ISSNLinking": "1362-0347"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "Am J Psychiatry. 2016 Oct 1;173(10 ):1015-1023",
      "PMID": "27079133"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Bipolar Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cyclothymic Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    }
  ],
  "CoiStatement": "Competing interests: RM is on the advisory boards and receives speaker fees from Lundbeck, Pfizer, AstraZeneca, Elli-Lilly, JanssenOrtho, Purdue, Johnson & Johnson, Moksha8, Sunovion, Mitsubishi, Takeda, Forest, Otsuka, Bristol-Myers Squibb and Shire. He has received research grants from Lundbeck, JanssenOrtho, Shire, Purdue, AstraZeneca, Pfizer, Otsuka and Allergan."
}